[1]闫德祺,白雪峰,刘群才.加味当归贝母苦参丸辅助经肝动脉化疗栓塞术治疗原发性肝癌临床研究[J].中国中医药信息杂志,2015,22(5):33-36.[doi:10.3969/j.issn.1005-5304.2015.05.010]
 YAN De-qi,BAI Xue-feng,LIU Qun-cai.Clinical Study on Modified Angelica Fritilaria Sophorae Pill Assisting TACE to Treat Primary Liver Cancer[J].zhongguo zhongyiyao xinxi zazhi,2015,22(5):33-36.[doi:10.3969/j.issn.1005-5304.2015.05.010]
点击复制

加味当归贝母苦参丸辅助经肝动脉化疗栓塞术治疗原发性肝癌临床研究

参考文献/References:

[1] Bester L, Meteling B, Boshell D, et al. Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer:a review of the literature[J]. J Med Imaging Radiat Oncol,2014,58(3):341-352.

[2] Wang F, Liu S, Shen Y, et al. Protective effects of N-acetylcysteine on cisplatin-induced oxidative stress and DNA damage in HepG2 cells[J]. Exp Ther Med,2014,8(6):1939-1945.

[3] Ma SK, Joo SY, Choi HI, et al. Activation of G-protein-coupled receptor 40 attenuates the cisplatin-induced apoptosis of human renal proximal tubule epithelial cells[J]. Int J Mol Med, 2014, 34(4):1117-1123.

[4] Motamedi F, Nematbakhsh M, Monajemi R, et al. Effect of pomegranate flower extract on cisplatin-induced nephrotoxicity in rats[J]. J Nephropathol,2014,3(4):133-138.

[5] De-Qi Yan, Yong-Qi Liu, Ying-Dong Li, et al. Tumor inhibition effects and mechanisms of Angelica sinensis and Sophorae flavescentis ait decoction combined with cisplatin in xenograft mice[J]. Asian Pacific Journal Cancer Prevention,2014,15(11):4609-4615.

[6] 舍雅莉,闫德祺,刘永琦,等.当归贝母苦参丸对顺铂化疗H22荷瘤小鼠肿瘤及肝脏、肾脏和胸腺组织病理形态的影响[J].中国中医药信息杂志, 2014,21(5):56-60.

[7] 闫德祺,刘永琦,李应东,等.当归贝母苦参丸对顺铂化疗H22荷瘤小鼠的抑瘤作用及对血清HIF-1α的影响[J].中成药,2014,36(7):1351- 1355.

[8] 李宜放,高向军.王晞星应用当归贝母苦参丸治疗肿瘤的经验[J].山西中医,2011,27(12):4-6.

[9] 中华人民共和国卫生部.原发性肝癌诊疗规范[J].临床肿瘤学杂志, 2011,16(10):929-946.

[10] 中华医学会中华放射学杂志编委会介入放射学组.肝癌介入治疗规范化条例(草案)[J].中华放射学杂志,2001,35(12):887-891.

[11] 杨学宁,吴一龙.实体瘤治疗疗效评价标准——RECIST[J].循证医学, 2004,4(2):85-111.

[12] 中华人民共和国卫生部.中药新药临床研究指导原则:第三辑[M]. 1997:347.

[13] 董庆芬.EP方案配合参芪扶正注射液对小细胞肺癌患者RECIST及KPS评分的影响研究[J].中国实用医药,2012,7(13):1-4.

[14] 孙燕.抗癌药急性及亚急性毒性反应分度标准(WHO标准)[J].癌症, 1992,11(3):24.

[15] Terzi E, Terenzi L, Venerandi L, et al. The ART score is not effective to select patients for transarterial chemoembolization retreatment in an Italian series[J]. Dig Dis,2014,32(6):711-716.

[16] Sangro B, Salem R. Transarterial chemoembolization and radioembolization[J]. Semin Liver Dis,2014,34(4):435-443.

[17] Turhan N, Esendagli G, Ozkayar O, et al. Co-existence of Echinococcus granulosus infection and cancer metastasis in the liver correlates with reduced Th1 immune responses[J]. Parasite Immunol,2015,37(1):16-22.

[18] Xu HM. Th1 cytokine-based immunotherapy for cancer[J]. Hepatobiliary Pancreat Dis Int,2014,13(5):482-494.

相似文献/References:

[1]迟惠昌,胡凤山,韩冬,等.疏肝健脾中药配合化学药物动脉灌注治疗中晚期原发性肝癌疗效观察[J].中国中医药信息杂志,2010,17(6):16.[doi:10.3969/j.issn.1005-5304.2010.06.008]
 CHI Hui-chang,HU Feng-shan,HAN Dong,et al.The Effectiveness of Liver-soothing and Spleen-strengthening Traditional Chinese Medicine Combined with Intra-arterial Infusion of Chemical Medicine for Advanced Primary Hepatocellular Cancer Patients[J].zhongguo zhongyiyao xinxi zazhi,2010,17(5):16.[doi:10.3969/j.issn.1005-5304.2010.06.008]
[2]宋爱英,杨丹,曹德胜,等.平调饮对原发性肝癌患者AFPmRNA、MAGE-1mRNA表达的影响[J].中国中医药信息杂志,2010,17(7):17.[doi:10.3969/j.issn.1005-5304.2010.07.008]
 SONG Ai-ying,YANG Dan,CAO De-sheng,et al.Effect of Pingtiaoyin on Expression of AFPmRNA and MAGE-1mRNA in Hepatocellular Carcinoma Patients[J].zhongguo zhongyiyao xinxi zazhi,2010,17(5):17.[doi:10.3969/j.issn.1005-5304.2010.07.008]
[3]胡兵,安红梅,沈克平.肝肾阴虚是原发性肝癌的发病基础[J].中国中医药信息杂志,2009,16(2):93.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(5):93.
[4]董海涛,赵炜,卢雯平,等.华蟾素并肝动脉介入治疗原发性肝癌38例临床观察[J].中国中医药信息杂志,2008,15(3):66.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(5):66.
[5]闫向勇,燕忠生,孟庆常,等.中医药配合肝动脉化疗栓塞治疗中晚期原发性肝癌疗效观察[J].中国中医药信息杂志,2008,15(11):71.
 [J].zhongguo zhongyiyao xinxi zazhi,2008,15(5):71.
[6]马晔琳,陈良良.岩舒注射液联合肝动脉栓塞化疗治疗原发性肝癌系统评价[J].中国中医药信息杂志,2011,18(7):29.[doi:10.3969/j.issn.1005-5304.2011.07.011]
 MA Ye-lin,CHEN Liang-liang.Systematic Review on Yanshu Injection Plus TACE for Primary Liver Cancer[J].zhongguo zhongyiyao xinxi zazhi,2011,18(5):29.[doi:10.3969/j.issn.1005-5304.2011.07.011]
[7]赵增虎,杜欣,刘秀芳,等.肝动脉化疗栓塞结合健脾理气中药治疗中晚期肝癌临床研究[J].中国中医药信息杂志,2006,13(1):62.
 [J].zhongguo zhongyiyao xinxi zazhi,2006,13(5):62.
[8]刘丽坤,王晞星.原发性肝癌重症并发症治验[J].中国中医药信息杂志,2006,13(5):81.
 [J].zhongguo zhongyiyao xinxi zazhi,2006,13(5):81.
[9]贺用和,韩静.中药制剂在原发性肝癌肝动脉化疗栓塞术治疗中的应用研究进展[J].中国中医药信息杂志,2006,13(12):95.
[10]孙丽红.参灵合剂对H22肝癌小鼠抑瘤及免疫调节的影响[J].中国中医药信息杂志,2012,19(7):44.[doi:10.3969/j.issn.1005-5304.2012.07.017]
 SUN Li-hong.Tumor-suppressing and Immunoregulation Effect on H22 Hepatocarcinoma Mice of Mixture of Panaxoside, Ganoderma Lucidum Polysaccharides Extract and Barbed Skullcap Herb Polysaccharides[J].zhongguo zhongyiyao xinxi zazhi,2012,19(5):44.[doi:10.3969/j.issn.1005-5304.2012.07.017]

更新日期/Last Update:

2015-04-15